瑞典、芬蘭和挪威因俄烏局勢升級,發布應對戰爭的新建議 News

瑞典、芬蘭和挪威因俄烏局勢升級,發布應對戰爭的新建議

(SeaPRwire) - 位處北歐的北歐國家,過去堅守「中立」立場,但隨著歐洲大陸安全局勢持續惡化,這些國家正採取預防措施,準備讓國民應對類戰爭的狀況。瑞典於週一發放數百萬份小冊子,說明戰爭爆發或國家遭遇意外危機時該如何應對。這本名為「危機或戰爭時」的小冊子,不僅因應歐洲安全情勢惡化而更新了六年前的舊版本,其內容也擴增了近一倍。向國民發放準備手冊對瑞典來說並非新鮮事,據報導,該國自二戰以來就一直沿用此做法,當時發行的第一版名為「如果戰爭來臨」。這份指南在冷戰期間曾更新過,但小冊子中間明顯突顯的一項指示被推到前面,指出:「如果瑞典遭到其他國家攻擊,我們絕不會放棄。所有宣稱停止抵抗的訊息都是虛假的。」瑞典繼芬蘭之後,在2022年俄羅斯入侵烏克蘭之後,於今年稍早加入北約。瑞典民防部長卡爾-奧斯卡·博林(Carl-Oskar Bohlin)也曾表示,「瑞典可能爆發戰爭」,此舉旨在敦促官員加快提升斯德哥爾摩的防禦能力。與瑞典不同的是,鄰國芬蘭儘管在二戰後維持數十年中立地位,但由於與俄羅斯接壤,始終保持較強的防禦態勢。烏克蘭戰爭持續1000天,澤倫斯基加強運用ATACMS、無人機和飛彈等空中選項但芬蘭也於週一發放了其危機應變指南,不過由於印刷小冊子的成本考量,該指南是以數位版本的形式發放給國民,英國廣播公司(BBC)報導指出。芬蘭政府表示,其「已做好自我防衛的充分準備」,並向國民保證,威脅赫爾辛基的敵對勢力並不一定會以直接的軍事行動出現,並指出,在緊急情況下,芬蘭人應預防長時間停電或斷水,以及銀行或網路服務中斷的情況。同樣地,1949年即為北約創始成員國的挪威,也發放了一份小冊子,敦促挪威人做好準備,以應對戰爭、危機或極端天氣長達一週的時間。已發放超過200萬份小冊子,敦促國民儲備罐頭食品、義大利麵、寵物食品、水、火柴、蠟燭、急救包和藥物,包括碘片。「碘片可以預防放射性碘的影響,並且只能在當局指示下服用。」挪威政府在其指示中表示。丹麥也在夏季鼓勵其國民確保儲備三天份的必需品,以協助度過危機情況。西方領導人持續密切關注俄羅斯在烏克蘭的戰爭,並警告莫斯科,任何攻擊北約國家的行為都將引發所有32個國家的聯合回應。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 ```
More
百萬美元獎勵任務:Immutable 與 YGG 攜手合作,推動 Web3 遊戲參與 Business

百萬美元獎勵任務:Immutable 與 YGG 攜手合作,推動 Web3 遊戲參與

(SeaPRwire) - 獎勵玩家金額高達$100萬,突顯了產業正轉向獎勵玩家並促進引人入勝、社群驅動的遊戲體驗的趨勢 雪梨,2024年11月18日 — 領先的Web3遊戲平台和生態系統,以及 (YGG),一個Web3公會協議,已宣布建立策略夥伴關係,並承諾投入$100萬用於透過任務獎勵來獎勵玩家。此次合作結合了兩個平台的優勢,為玩家、開發者和公會帶來新的盈利機會,為整個Web3遊戲生態系統創造價值。 作為這項策略聯盟的一部分,Immutable和YGG專注於擴展遊戲產品並增強在無縫、使用者友善的生態系統中的玩家參與度。YGG將向其社群介紹Immutable遊戲,為玩家創造新的機會。為進一步增強使用者體驗,YGG將在2025年初整合Immutable的Passport(一個使用者友善的自我託管錢包解決方案)和zkEVM擴展解決方案。 為進一步推進合作,Immutable正在贊助YGG Play峰會的許多方面,包括擔任YGG Play峰會的白金贊助商,贊助YGG聚會,並贊助將於馬尼拉11月22日舉行的首屆GAM3獎頒獎典禮。 「我們與YGG的整合是遊戲發展的一個關鍵時刻,」Immutable聯合創始人兼總裁Robbie Ferguson表示。「這項夥伴關係和投資將使玩家能夠在蓬勃發展的生態系統中體驗Web3遊戲的真正潛力。YGG和Immutable共同相信Web3遊戲的可擴展性和未來,我們致力於為所有使用者支援蓬勃發展的社群。」 「與YGG和Immutable的合作是關於與玩家分享實際獎勵,」YGG聯合創始人Gabby Dizon說。「有意義的獎勵能推動參與度並建立社群忠誠度。這不僅僅是激勵措施;而是為我們的玩家和公會成員提供在他們熱衷的遊戲中蓬勃發展並在Web3領域共同成長的方法。」 這項$100萬的承諾突顯了Immutable和YGG共同的願景,即透過優先考慮玩家和社群來重新定義遊戲。他們共同為Web3遊戲更具包容性和永續性的未來鋪平了道路。 關於Immutable是一家全球領先的遊戲公司,其使命是透過讓構建出色的區塊鏈遊戲變得安全且容易,為每位玩家帶來數位所有權。Immutable由James Ferguson、Robbie Ferguson和Alex Connolly於2018年共同創立,總部位於雪梨,擁有250多名員工,並得到Temasek、騰訊、Coinbase、BITKRAFT Ventures、King River Capital、Galaxy Interactive等頂級轉型科技投資者的支持。 Immutable遊戲平台讓遊戲工作室和獨立開發者能夠安全可靠地在以太坊上輕鬆構建和發布成功的遊戲。產品套件包括針對易用性進行優化的預建解決方案,可幫助開發者更快地進入市場,而無需犧牲安全性或玩家體驗。開發者可以獲得個性化的Web3指導、社群現場支援以及訪問遊戲中最大的生態系統。 Immutable是第一個向以太坊社群提供零知識(zk)擴展解決方案的遊戲平台,並為開發者提供多種基於zk的擴展選項,包括基於StarkWare技術的Rollup Immutable X和由Polygon驅動的Immutable zkEVM。 Immutable Games是Web3遊戲開發和發行的全球領導者,由一支世界級團隊支持,這些團隊在將遊戲帶給數百萬玩家方面擁有久經考驗的記錄。該工作室率先推出了世界上第一款熱門NFT交易卡牌遊戲,目前正在開發備受期待的行動RPG。除了自身的高品質遊戲外,Immutable Games還與第三方遊戲開發者合作,為他們提供一流的策略和執行專業知識,旨在確保Immutable生態系統中部署的每個Web3遊戲都能獲得成功。 更多資訊,請瀏覽: 註冊在 上遊玩 加入Immutable社群:、、、、和 關於Yield Guild GamesYield Guild Games (YGG) 是一個Web3公會協議,讓玩家和遊戲公會能夠找到他們的社群、發現遊戲並一起升級。作為一個專注於Web3遊戲的遊戲公會網路,YGG提供了一個機會均等的支援系統,讓其成員能夠在遊戲和生活中成為強大的玩家。 YGG讓其公會社群能夠在鏈上組織,為公會提供訪問其基礎設施的權限,以便他們能夠擴展規模並根據其專長獲得機會。透過YGG的任務計劃,例如超級任務和公會進階計劃(GAP),YGG成員可以從其基於成就的聲譽系統中受益,並建立其鏈上身份。 從其在菲律賓的根基到其全球區域公會網路以及與100多個Web3遊戲和基礎設施專案的合作夥伴關係,YGG服務於一個不斷擴大的遊戲玩家和區塊鏈愛好者社群。 資料來源 Immutable本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
SKRR Exploration Inc. 宣佈股份合併 Business

SKRR Exploration Inc. 宣佈股份合併

(SeaPRwire) - 溫哥華,卑詩省, 2024年11月19日 – SKRR Exploration Inc. (TSXV: SKRR) (FSE: B04Q) (“SKRR” 或“公司”) 宣佈其普通股進行合併(“合併”),每四(4)股合併前普通股合併為一股(1)合併後普通股。截至本新聞稿發佈之日,公司已發行和流通的普通股為 19,375,371 股,公司預計合併後將約有 4,843,842 股普通股發行和流通。合併後收到的普通股數量將四捨五入到最接近的整數(0.5 或更大則向上取整,小於 0.5 則向下取整),每位股東持有的普通股流通股比例與合併前相同。根據其條款,在擬議合併實施後,將按比例調整待行使的未償權證和認股權證可發行普通股的行使價格和數量。 根據《商業公司法》( 不列顛哥倫比亞省) 和公司的章程,合併已由公司董事會決議批准。 合併須經 TSX 創業板(“交易所”)批准。公司預計,合併後的股份將在與交易所協商確定的日期開始進行合併後的交易,該日期一旦確認,將在隨後的新聞稿中公佈。公司的名稱和交易代碼將保持不變。公司將發佈另一份新聞稿,公佈合併生效日期及其新的 CUSIP 和 ISIN 編號。 關於 SKRR Exploration Inc. SKRR 是一家加拿大貴金屬和基本金屬勘探公司,在薩斯喀徹溫省擁有礦產,該省是全球排名最高的礦業區之一。主要的勘探重點是薩斯喀徹溫省的 Trans-Hudson 走廊,尋找世界一流的鈾、貴金屬和基本金屬礦床。Trans-Hudson 造山帶——儘管在地質學方面非常著名,但在薩斯喀徹溫省的勘探程度卻非常低。SKRR 致力於所有利益相關者,包括股東、所有合作夥伴及其經營所在環境。 代表董事會 Sherman Dahl總裁兼首席執行官電話:250-558-8340 TSX 創業板及其監管服務供應商(該術語定義於 TSX 創業板的政策中)均不對本新聞稿的充分性或準確性承擔責任。 前瞻性資訊 本新聞稿包含適用證券法定義的“前瞻性資訊或陳述”,可能包括但不限於與擬議合併和交易所批准相關的陳述,與公司及其項目的技術、財務和業務前景、其目標及其他事項相關的陳述。本新聞稿中除歷史事實陳述以外的所有陳述,均屬於前瞻性陳述,這些陳述涉及公司預期發生的事件或發展。儘管公司相信這些前瞻性陳述中表達的預期是基於合理的假設,但這些陳述並不能保證未來的業績,實際結果可能與前瞻性陳述中的結果存在重大差異。這些陳述和資訊基於許多關於公司未來業務策略和經營環境的假設,包括金屬價格、實現其目標的能力、獲得設備和人員以執行工作計劃的能力、一般業務和經濟狀況不會發生重大不利變化的情況、如有需要,可在合理條件下獲得融資。此類前瞻性資訊反映了公司對未來事件的看法,並受風險、不確定性和假設的影響,包括與勘探結果解釋相關的風險、與勘探和成本估計固有不確定性相關的風險以及意外成本和費用的潛在風險以及在 SEDAR+ 上公司簡介中提交的其他風險。未來勘探、開發或採礦結果可能與公司的預期不符。可能導致實際結果與前瞻性陳述中結果存在重大差異的因素包括但不限於:持續獲得資本和融資以及普遍的經濟、市場或業務狀況、未能為工作計劃獲得人員和設備、惡劣的天氣和氣候條件、未能獲得或維持所有必要的政府許可、批准和授權、金、銅、鈾和其他金屬價格下降、未能獲得或維持社區接受度(包括原住民)、成本增加、訴訟以及交易對手方未能履行其合同義務。除非法律規定,否則公司不承擔更新前瞻性陳述或前瞻性資訊的義務。 資料來源 SKRR Exploration Inc.本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 ```
More
Brook Gaming 推出全相容 PS5 產品解決方案,支援所有 PS5 遊戲 Business

Brook Gaming 推出全相容 PS5 產品解決方案,支援所有 PS5 遊戲

(SeaPRwire) - 台北, 2024年11月19日 — 在最新PlayStation 5 Pro發布引發熱潮之後,台灣遊戲配件品牌Brook Gaming推出了兩款專為PlayStation 5遊戲設計的新配件。這些新產品包括Wingman FGC 2轉接器,支援過去20年來超過150款有線控制器,為所有PS5遊戲提供跨平台和跨世代的相容性。Brook Gaming還推出了其著名的Brook Fighting系列的最新產品Gen-5X系列格鬥板,讓玩家可以自定義他們的遊戲體驗以符合他們獨特的喜好。 Brook Gaming相信「每個玩家都應該能夠以自己獨特的方式享受遊戲的樂趣」。這些新的PlayStation 5配件讓玩家可以完全控制他們的遊戲體驗,自由選擇他們喜歡的控制器和格鬥搖桿。 專注於PS5的Wingman FGC 2轉接器支援完整的PS5遊戲目錄,允許過去二十年來的150多款有線控制器與PS5遊戲在不同平台和世代之間無縫運行。 這種令人印象深刻的相容性延伸到Mad Catz、Qanba、Hori和Razer等品牌的熱門控制器,以及HITBOX、Snackbox Micro和Victrix Gambit等較新的全按鈕控制器,以及Xbox Elite Series 2控制器。它還包括對飛行模擬器控制器和太鼓達人鼓控制器的支援。 此外,對於重視獨特、可自定義街機控制器的格鬥遊戲社群 (FGC) 而言,Brook Gaming已成為尋求修改或自建自定義街機控制器的玩家的首選。Brook Gaming的Brook Fighting系列的最新成員Gen-5X系列格鬥板,讓玩家可以輕鬆享受PS5遊戲。與市面上的其他產品不同,Gen-5X系列格鬥板支援所有PS5遊戲,而不仅仅是格鬥遊戲。這個系列也是第一個配備RGB LED燈光以實現自定義燈光效果和OLED螢幕以實現清晰、方便的設定顯示的系列,從而提高了精度和調整的便利性。 Brook Gaming的終極PlayStation 5解決方案系列產品現已通過全球經銷商和Brook Gaming的電子商務渠道銷售。作為Street Fighter League: Pro-US 2024的官方贊助商,Brook Gaming與日本遊戲巨頭Capcom合作,展現出無縫且無與倫比的競爭體驗。 請關注Brook Gaming的官方X(前身為Twitter)頁面和以獲取最新更新。不要錯過使用最佳遊戲創新來提升您的PlayStation 5體驗的機會。 關於Brook Gaming從全按鈕盒和高性能格鬥板到跨平台控制器轉接器和怪物自動捕捉器,總部位於台灣的遊戲硬體公司Brook Gaming一直以來都在為全球玩家創造無限的遊戲樂趣。無論是使用現代控制器玩您的復古遊戲機,為您的遊戲添加新功能,還是為您的比賽設計終極街機搖桿,Brook Gaming都能為您提供解決方案。在Brook Gaming——您的遊戲,我們的玩法。更多資訊請瀏覽 聯絡人:Katy Ho, 資料來源 Brook Gaming (Zeroplus Technology Co., Ltd.)本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
多款有機胡蘿蔔因大腸桿菌O121受污染而被召回 Business

多款有機胡蘿蔔因大腸桿菌O121受污染而被召回

(SeaPRwire) - 安大略省渥太華, 2024年11月18日 – 產品:多種品牌的 有機胡蘿蔔 問題:食品 – 微生物污染 – 大腸桿菌 – 其他病原體 分佈:全國 資料來源 Canadian Food Inspection Agency (CFIA)本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Scania開放數位生態系統,適用於多元化及混合品牌車隊
“` Business

Scania開放數位生態系統,適用於多元化及混合品牌車隊 “`

(SeaPRwire) - SÖDERTÄLJE,瑞典,2024年11月19日 — Complete Fleet 概念是Scania針對當今複雜且多層次的運輸業現狀提出的解決方案。通過將其整個車隊和拖車整合到Scania全系列的數位服務中,承運商不僅可以連接他們的Scania車輛,還可以連接其他卡車製造商的車輛。 今天,Scania推出了其Complete Fleet數位服務概念。無論車輛品牌或類型如何,客戶車隊中的所有車輛和拖車現在都可以同樣全面地訪問Scania不斷擴展的數位服務,例如定位、行車記錄儀、性能報告和服務規劃。這同樣適用於多個品牌和混合燃料車隊,包括燃氣車、生物燃料車、電池電動車、燃油引擎車和插電式混合動力車。 Complete Fleet方法將使運輸公司所有者能夠更好地了解、控制和提高整個車隊的能源效率。這反映了Scania的理解,即我們的許多忠實客戶在其車隊中也有其他品牌的車輛,以及各種类型的卡車車身應用和拖車。 此外,當今歐洲運輸業的道路上拖車數量明顯多於卡車,而且拖車的服役時間往往遠長於車輛。在許多情況下,仍在車隊中使用的較舊拖車未連接,這意味著它們很難定位,更難以管理。 到目前為止,許多需要全面了解其車隊的運輸公司可能選擇為管理其各種車輛或拖車而後裝一種特定的遠程信息處理系統。這是一種低效且成本高昂的方法,可能意味著他們的首要運輸資產——他們的營運工具——經常在維修廠,而它們應該在路上維持供應鏈並為其所有者賺錢。 一些運輸公司所有者選擇堅持使用特定於其不同車輛品牌的工廠安裝的遠程信息處理系統,但这會使整體車隊規劃成為一個支離破碎且低效的過程。部分車隊缺乏連接或缺乏總體概覽會對利用率和效率產生負面影響,並且是整體運輸營運的另一個複雜因素。 Complete Fleet現在為車隊所有者提供了一個更簡單、更有效的多功能選項。更好的是,通過現有的數據共享和其他促成協議,在Complete Fleet方法中將混合車隊整合到Scania的數位生態系統中是一個簡單快捷的過程,可以在My Scania中完成。 所有這些加起來,客戶可以按可擴展的方式連接和控制其整個混合車隊的多樣化卡車和拖車,為整個單元(卡車和拖車)提供高效的規劃,並為他們提供完整的概覽和透明度。 “Scania希望與我們的客戶一起走過他們的旅程,而Complete Fleet的推出正是我們如何支持他們實現跨系統兼容性,現在和將來,”Scania服務產品組合和交付代理負責人Andrea Wetterberg表示。 “通過提供一個統一且不斷擴展的數位服務,在所有車輛品牌和拖車上提供一致的數據,我們為當今的運輸公司所有者提供了整個車隊的透明度和安全性、成本效益和節能。” 如需了解更多產品信息,請聯繫: Pranav Nayak,產品經理,Complete Fleet數位運輸和充電服務。電話:+46 (0)85 537 21 25。 此信息由Cision提供 以下文件可供下載: 24217-014 16×7 資料來源 Scania本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More

每個人都需要一場《破-地獄》- 當我們談論死亡時我們在談論什麼?

香港, 2024年11月20日 - (亞太商訊 via SeaPRwire.com) - 近日,由香港兩代喜劇泰斗許冠文與黃子華攜手新晉入圍「金像獎」最佳女主角的衛詩雅等主演的電影《破•地獄》上映首周末就刷新了香港電影九項紀錄,一度躍升香港電影「現象級作品」,熱度之高甚至吸引大批內地觀眾專程南下觀影。儘管《破•地獄》暫未引進內地,但其在豆瓣上已收穫超1600條影評,評分高達8.8分。《破•地獄》究竟是一部什麼樣的電影,在香港上映即爆火的同時,還能吸引內地觀眾專程赴港觀看?聚焦殯葬業的港版《入殮師》?《破•地獄》聚焦香港獨特的殯葬儀式,由一老一新兩位殯葬從業人員對殯葬服務創新與傳統理念的衝突為切入點,深入探討生死議題。談到殯葬題材電影,大家難免想到斬獲第81屆奧斯卡最佳外語片獎的日本電影《入殮師》。影片講述因失業而機緣巧合成為入殮師的小林大悟,在跟隨老師傅學習工作的過程中,逐步理解並熱愛上這份工作,同時藉由人物在工作中遇到的生死離別,乃至自身面對父親死後的自我和解,實現人生升華的過程。《破•地獄》亦有相似之處,黃子華飾演的主角魏道生原是婚禮策劃師,但由於經濟環境的變化,無奈改行成為殯儀經紀人。該影片摒棄了傳統的一老帶一新的敘事模式來展現小眾職業,而是緊密圍繞「破地獄」這一主題,深刻演繹了關於死亡與希望的內涵。深諳於滿足客戶需求的道生(黃子華飾)入行後,頻頻與代表傳統的喃嘸師傅文哥(許冠文飾)因理念不合而產生諸多衝突。文哥作為從事道教法事的神職人員,對葬禮有着嚴苛的傳統堅持,而道生則帶着婚禮策劃的思維模式,不囿於傳統習俗。兩種迥異的理念在一次次葬禮籌備過程中不斷碰撞,但在一段段戲劇衝突後,最終實現互相理解和彼此尊重的結局。所謂「破地獄」,是道教的一種喪禮科儀法式。此處的「破」並非破壞,而是指開啟九幽地獄之門,讓亡者重新獲得光明,擺脫苦海之苦。具體而言,火盆和九塊瓦片擺放在靈堂正中央,喃嘸師傅先燒鬼頭及破五方陣,並透過穿步和破瓦等一系列動作,運用道法打開地獄之間的通道,照亮幽獄,引領先人從地獄中解脫。影片藉由「破地獄」儀式——這一香港非物質文化遺產切入,從文哥道教法事形而下的「破地獄」,引申到道生所說的「不止死人要超渡,生人也需要破地獄,生人都有好多地獄。」這一形而上內涵,道出了殯葬行業服務生者的本質,也擊中了觀眾反思生死、珍惜人生,以及重新看待生活的情感需求。現實中的殯葬行業有那麼理想化嗎?電影能夠大獲成功,除了紮實的劇本、演員演技的加持,最重要的是能夠接地氣地去觸達受眾。這一點,可以說是《破•地獄》成功的關鍵。無論是紮根香港傳統文化的「破地獄」儀式,還是幾場白事過程中表現出的現代人對殯儀的新需求,都可以稱得上緊扣社會脈動。比如片中一位不願相信摯親兒子離世的母親,欲將遺體真空防腐保存,寄望未來科技可以令兒子復活。這不禁讓人想到今年年初登上熱搜的著名音樂人包小柏用AI「復活」女兒的新聞,一度引發大眾對於科技與倫理、逝者與生者間關係的討論。有意思的是,這樣一個看似戲劇化的橋段,經導演透露卻是真人真事改編。在另一場白事上,蘇蘇由於沒有正式身份,被拒絕參加所愛之人最後的葬禮儀式。察覺到兩人關係的道生,偷偷贈其一條藏有死者骨灰的項鍊,最終實現生者的「破地獄」。而在現實生活中,骨灰製成晶石珠寶產品的技術早已問世多年,並已實現產業化發展。可以說,道生與文哥的碰撞恰恰也是傳統殯葬行業所經歷的創新與傳統碰撞的縮影,正是在整個行業不斷重視生者的精神需求的背景下,大眾才有了越來越多個性化的選擇,讓每個人在面臨生離死別之時,都能夠實現「破地獄」的和解過程。以港股上市的中國最大殯葬服務提供商福壽園(01448)為例,在三十年的發展過程中,從最初探索期的全國擴張,慢慢探索公益項目的踐行,再到品牌藉由人文紀念館的建成進入文化領域,傳播生命文化,傳承紅色記憶,升華人生觀和企業核心價值。作為行業領軍者,福壽園從未將殯葬服務定位為死者的生意,而是開放接受社會觀念的變革,聚焦生者的需求,擁抱新觀念、新技術,甚至主動向社會、向行業、向大眾輸出生命教育的理念,才實現了當下牢牢穩固行業第一把交椅的地位。據悉,福壽園的公益事業自1994年從上海出發,內容涵蓋慈善救助、精神救援、安寧療護、優撫助學、生命教育、環境保護等多個領域,歷經30年,輻射40餘座城市。針對生命教育這一門頗具挑戰性的「課程」,福壽園積極組織探索,為了走近年輕群體,近年還開發了生命桌遊等項目,引發普遍好評。基於全方位的配套服務支持,福壽園進一步推出生前契約這一戰略支點業務,成為國內最早普及生前契約的企業之一。以往中國社會對死亡總是諱莫如深、充滿禁忌,但隨着人口老齡化,越來越多的人希望儘早安排好自己的身後事。面對這樣的新需求,福壽園積極探索生前契約業務模式,為民眾提供生命規劃建議和善終管理方案,為機構、政府提供長者服務解決方案。僅2024年上半年,福壽園累計簽訂的生前契約就高達11,923份,同比增長28.6%。不斷推出滿足生者需求的業務不僅為福壽園帶來了更多業績上的回饋,更重要的是,也為生者和死者開闢出了一條從執念地獄解脫的「破地獄」之道。此外,福壽園積極擁抱前沿科技,電影中提到的骨灰晶石產品也早已被福壽園帶到國內。2021年,上海福壽園建成超微佔地園區"藏晶苑"專門用於存放"生命晶石"。42平方米的地下室內葬,可安放8400個"生命晶石",每塊晶石平均佔地僅0.005平方米。地上廣場建有記載生命影像的互動電子屏,形成生者與逝者共享的景觀空間和紀念場所。今年4月,福壽園再次宣佈運用科技革新行業,以「數智人虛擬發佈」形式舉辦2024清明發佈會。通過數字形象發言人Jason介紹了福壽園3JI生命服務理念——「記號做美,記載做厚,紀念做長」,並從產品、科技、公益、文化等方面,發佈了生命美學產品、天堂小區計劃、數字家祠、虛擬數智人以及「生前契約 • 安善計劃」、生命智庫等系列行動及計劃。在VR技術、AI技術、數字人技術等一系列尖端科技的加持下,電影中陷入逝子之痛的母親的天馬行空想法未來或將成為現實,至親或將以數位永生的形式陪伴在生者身邊,死者的地獄與生者的地獄也有望在科技這一道法下,重獲光明脫離苦海。儘管在創新領域走在行業前沿,但福壽園同樣尊重文哥這樣的傳統支持者。在全國擴張的過程中,福壽園充分尊重各地傳統殯儀習俗,通過配套基礎服務實現了各地「接地氣」的服務,滿足生者的本地化需求。打開福壽園的首頁,首先映入眼帘的是八個大字——「感知生命 綻放人生」。正如《破•地獄》的拍攝地香港紅磡,多因其作為香港重要的交通樞紐(火車站)及最著名的演唱會聖地(紅館)而被人熟知。但很少人知道紅磡亦是香港最大的殯儀區,匯聚了大量殯葬相關的店鋪,形成獨特的香港殯葬文化。也許每一天經過紅磡的旅人,都早已對殯葬區見怪不怪、視而不見,但《破•地獄》恰恰告訴我們,只有正視死亡,方能重新認知生之意義,就像道生因文哥之死改變了不婚不育的堅持,接受了女友肚中新生命的現實。如果說死亡是每個人的終點站,那真正重要的恰恰是我們所選擇的旅程,以及陪伴我們每一段旅程的每一個人。正如《破•地獄》中的台詞,「有機會來到這個世界已經賺了,何必介懷什麼時候下車,不如好好欣賞沿途的風景。」而這也許便是這部電影想要傳遞給我們最重要的感悟。本文來源於「今日熱點網」 Copyright 2024 亞太商訊 via SeaPRwire.com.
More
Darwinbox Rises as a Challenger in Gartner’s Magic Quadrant for Cloud HCM Suites ACN Newswire

Darwinbox Rises as a Challenger in Gartner’s Magic Quadrant for Cloud HCM Suites

MANILA, Nov 18, 2024 - (ACN Newswire via SeaPRwire.com) - Darwinbox, a globally recognized HR technology platform, has been named a Challenger in the 2024 Gartner Magic Quadrant for Cloud HCM Suites for enterprises with over 1,000 employees. This significant recognition marks Darwinbox’s continuous rise in the HR tech industry, with the company standing out as the only provider worldwide to move up a quadrant this year.Trusted by 950+ enterprises globally, today some of the largest conglomerates (top 2 out of 5), banking (top 4 out 5), retail and real estate brands in Philippines such as Security Bank, Gokongwei Group, BPI, Starbucks, URC, Filinvest, SM Prime and more are modernizing their HR with the mobile-first and agile platform. Known for its advanced AI capabilities and user-focused experience, Darwinbox is increasingly becoming the preferred choice for enterprises in the Philippines. Since its expansion to this market in 2019, the company has invested heavily in localizing its platform to meet the unique needs of businesses in the region.“Our rise to Challenger status is driven by our commitment to building a modern, global HCM platform, supported by AI-driven innovation and user-centric design.We’re leading the way with cutting-edge technologies like Gen-AI, addressing the complexities of global enterprises with multi-country payroll solutions, and continuously evolving our platform to not only solve for today’s needs but tomorrow’s challenges” said Chaitanya Peddi, Co-founder of Darwinbox. “Philippines is a digital-first market and we’ve made deep R&D investments to deliver highly localized solutions that solve for the diverse needs of businesses in the region. With a growing number of organizations experiencing the transformative impact of Darwinbox, we’re committed to doubling down on our expansion in the region”AI with Practical ImpactDarwinbox’s AI solution, Darwinbox Sense, has been instrumental in helping organizations make better, data-driven HR decisions. By embedding AI in daily workflows, Darwinbox enables Filipino organizations to gain insights into employee performance, reduce hiring biases, and understand workforce sentiment—all critical for fostering an inclusive and engaged workplace. Its intelligent tools, like conversational analytics, automated workflows, and payroll anomaly detection, deliver insights exactly when and where they’re needed.Flexible Platform for Unique Local NeedsRecognizing the need for adaptable solutions, Darwinbox’s Extensibility Suite offers Filipino HR teams the ability to tailor and automate workflows through low-code, no-code tools. This flexibility enables companies to streamline operations with minimal IT dependency, allowing HR teams to quickly respond to changing business needs.Mobile-First Design for High EngagementUnderstanding the importance of mobility in the Philippines, where many employees work remotely or in the field, Darwinbox’s platform is built to engage a diverse range of users across different work environments. Its mobile-first design ensures seamless connectivity, allowing organizations to reach every employee, from frontline workers to office-based teams, fostering a unified and engaged workforce.Talent Management for Skills DevelopmentThe platform’s talent management features, highly rated in Gartner’s report, support Filipino companies in building a robust skills-based workforce. Darwinbox’s AI-driven career planning tools and Talent Hub offer managers and employees personalized guidance for career development, helping Filipino businesses retain top talent and enhance workforce growth.For More InformationRead the blog, "Darwinbox Rises as a Challenger in 2024 Gartner® Magic Quadrant™ for Cloud HCM Suites for 1,000+ Employee Enterprises," by Chaitanya Peddi, Co-founder, Darwinbox.Read a complimentary copy of the Gartner report on the Darwinbox website.Gartner DisclaimerGartner does not endorse any vendor, product or service depicted in our research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.GARTNER is a registered trademark and service mark, PEER INSIGHTS and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.Gartner, Magic Quadrant for Cloud HCM Suites for 1,000+ Employee Enterprises, 23 October 2024, Ranadip Chandra, et. Al.About DarwinboxFounded in 2015, Darwinbox is a global HR tech leader that empowers enterprises to better manage their talent with new-age employee experiences and disruptive AI-powered technology. Its cloud-based Human Capital Management (HCM) software caters to an organisation's HR needs across the entire employee lifecycle. Darwinbox is trusted by over 3 million employees from more than 900 enterprises across 130 countries. Darwinbox has been backed by global investors like TCV, Microsoft, Salesforce Ventures, Peak XV, Lightspeed and Endiya Partners among others.More at www.darwinbox.comFor media inquiries, please contact: Rishita.chiranewala@darwinbox.in Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Anticancer Agent “TASFYGO Tablets 35mg” (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements JCN Newswire

Anticancer Agent “TASFYGO Tablets 35mg” (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements

TOKYO, Nov 20, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that it has launched fibroblast growth factor receptor (FGFR) selective tyrosine kinase inhibitor “TASFYGO® Tablets 35mg” (generic name: tasurgratinib succinate) in Japan for the treatment of patients with unresectable biliary tract cancer with FGFR2 gene fusions or rearrangements that progressed after cancer chemotherapy. The product received manufacturing and marketing approval in Japan on September 24, 2024, and was published in Japan’s National Health Insurance Drug Price List today.Discovered in-house by Eisai’s Tsukuba Research Laboratories, TASFYGO is an orally available novel tyrosine kinase inhibitor that demonstrates selective inhibitory activity against FGFR1, FGFR2 and FGFR3.The approval of TASFYGO in Japan is based on data such as the results of a multicenter, open-label, single- arm clinical phase II trial (Study 201) conducted by Eisai in Japan and China.1 A companion diagnostic test to detect FGFR2 gene fusions or rearrangements for the use of TASFYGO in biliary tract cancer, “AmoyDx® FGFR2 Break-apart FISH Probe Kit” by Nihon Stery, Inc. (Headquarters: Tokyo) was approved in August 2024.(2)The estimated number of patients in Japan with biliary tract cancer is approximately 22,000,(3),(4) with approximately 25% of the five-year relative survival rate,(3) making it an intractable cancer with the second worst prognosis following pancreatic cancer. Since drug therapy options are limited in comparison with other cancers, it is a disease with significant unmet medical needs. FGFR2 gene fusions or rearrangements are observed in approximately 5-14% of intrahepatic cholangiocarcinoma, which accounts for 15-30% of biliary tract cancers.(5),(6),(7) FGFR genetic aberrations such as the gene fusions are known to be deeply involved in the proliferation, survival and migration of cancer cells as well as tumor angiogenesis and drug resistance. As these genetic aberrations in FGFRs have been observed in various other types of cancers as well as biliary tract cancer, there is growing interest in FGFRs as a promising target for cancer therapy.TASFYGO is produced at the Kawashima Industrial Park (Gifu Prefecture), using innovative Continuous Manufacturing and Real Time Release Testing, a manufacturing technology that ensures product quality within production processes. Continuous Manufacturing is a production method in which processing is carried out continuously from raw material input to formulation. By incorporating real-time quality monitoring technology, multiple manufacturing processes are integrated, enabling automatic production. This method allows for higher quality control compared to conventional processes that focus on product release testing, by utilizing data within the manufacturing process and reducing human-error through automation.Eisai aims to make continuous efforts to meet the diversified needs of and increase the benefits provided to patients with cancer, their families, and healthcare professionals, by delivering TASFYGO as a new treatment option for biliary tract cancer with FGFR2 gene fusions or rearrangements.Product InformationBrand name: TASFYGO® Tablets 35mg Generic name: Tasurgratinib succinateIndications: Unresectable biliary tract cancer with FGFR2 gene fusions or rearrangements that progressed after cancer chemotherapyDosage and Administration: The usual adult dose of tasurgratinib is 140mg orally once daily under fasting conditions. The dose may be reduced appropriately according to the condition of the patient.National Health Insurance (NHI) Drug Price: TASFYGO Tablets 35 mg: ¥ 15,378.70 (per 1 tablet) Packaging: TASFYGO Tablets 35 mg: 56 tablets (14 tablet PTP sheet X 4)About “TASFYGO® Tablets 35mg” (tasurgratinib succinate, Development Code: E7090)Discovered in-house by Eisai’s Tsukuba Research Laboratories, TASFYGO is an orally available novel tyrosine kinase inhibitor that demonstrates selective inhibitory activity against fibroblast growth factor receptors (FGFR) FGFR1, FGFR2 and FGFR3. Distinct from prior known FGFR inhibitors, TASFYGO has a basic structure which lacks the dimethoxyphenyl moiety, and in a kinetic interaction analysis study, it was observed that TASFYGO demonstrates antitumor activities due to inhibition of kinase activity with a binding mode (Type V) that exhibits rapid and potent binding as well as high selectivity to FGFR.(8),(9)In non-clinical studies for biliary tract cancer, NIH/3T3 cells expressing FGFR2-AHCYL1, FGFR2-KCTD1, FGFR2-BICC1 or FGFR2-TXLNA as FGFR2-fusion genes, provided by the National Cancer Center Japan, were used. The antitumor activity of TASFYGO against FGFR2 gene fusion-positive cancers was confirmed in these models by evaluating its effect on anchorage-independent growth and subcutaneously transplanted tumor growth in mice.(9)A Phase I clinical trial is underway in Japan in patients with estrogen receptor-positive and HER2-negative breast cancer.About Real Time Release TestingReal Time Release Testing is a quality control approach that ensures the quality of final products based on data from within the manufacturing process. Applying Real Time Release Testing requires a quality design approach based on Quality by Design (QbD), an advanced development method for manufacturing processes. QbD is a development method that emphasizes process control based on profound understanding of manufacturing processes, rather than conventional quality assurance methods which mainly focus on product release testing.Eisai integrates Process Analytical Technology (PAT) into QbD to achieve a higher level of quality control by managing critical attributes of pharmaceuticals within the production process.(1) Furuse J. et al. Pivotal single-arm, phase 2 trial of tasurgratinib for patients with fibroblast growth factor receptor (FGFR)-2 gene fusion-positive cholangiocarcinoma (CCA). 2024 ASCO Gastrointestinal Cancers Symposium; Abstract No. 471. https://ascopubs.org/doi/pdf/10.1200/JCO.2024.42.3_suppl.471(2) AmoyDx® FGFR2 Break-apart FISH Probe Kit Approved as Companion Diagnostic for Eisai’s Tasurgratinib in Japan. Available at: https://www.amoydiagnostics.com/about/press-releases/245 Last accessed: September 2024.(3) Latest statistics, Cancer Information Service, National Cancer Center, Japan. (Japanese only)(4) The 23rd Follow-up Survey Reports for Primary Liver Cancer Cases in Japan (2014-2015), 2023. (Japanese only)(5) Arai Y. et al., Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma, Hepatology, 2014, 59, 1427-1434.(6) Maruki Y. et al., Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study), J Gastroenterol. 2021; 56(3), 250-260.(7) Tsujie M. et al., Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma, Jpn J Clin Oncol. 2021; 51(6): 911-917.(8) Miyano SW. et al., E7090, a Novel Selective Inhibitor of Fibroblast Growth Factor Receptors, Displays Potent Antitumor Activity and Prolongs Survival in Preclinical Models, Molecular Cancer Therapeutics, 2016, 15, 2630-2639.(9) Kawano S. et al., Antitumor Activity of Tasurgratinib as an Orally Available FGFR1-3 Inhibitor in Cholangiocarcinoma Models With FGFR2-fusion, Anticancer Research, 2024, 44, 2393-2406.Media Inquiries:Public Relations Department, Eisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2024 JCN Newswire via SeaPRwire.com.
More
健倍苗苗公佈二零二五財年中期業績 純利飆升53.4%至95.9百萬港元 ACN Newswire

健倍苗苗公佈二零二五財年中期業績 純利飆升53.4%至95.9百萬港元

業績亮點- 收益增長22.1%至約4.0億港元- 毛利上升20.3%至約2.1億港元- 權益持有人應佔綜合溢利增長53.4%至95.9百萬港元- 中期股息每股5.50港仙,同比增長59.4%- 憑藉有效的整合及營銷策略,旗艦品牌何濟公及保濟丸實現強勁增長- 濃縮中藥顆粒劑業務展示穩健增長勢頭,為經營業績帶來貢獻香港, 2024年11月19日 - (亞太商訊 via SeaPRwire.com) - 健倍苗苗(保健)有限公司 (「健倍苗苗」或「公司」;股份代號:2161,連同其附屬公司統稱「集團」)為香港品牌保健品的領先營銷商及分銷商,集團今天公佈截至二零二四年九月三十日止六個月(「二零二五財年中期」或 「報告期」)的中期業績。報告期內,集團的品牌醫療保健業務表現出色。收益總額錄得約4.0億港元,較去年同期顯著增長22.1%。集團的毛利為2.1億港元,同比增長20.3%。於二零二五年財年上半年,權益持有人應佔綜合溢利增長53.4% 至95.9百萬港元。集團優秀的表現主要受惠於集團旗艦品牌的強勁銷售勢能,尤其是品牌藥分部的何濟公和品牌中藥分部的保濟丸。此外,集團的濃縮中藥顆粒業務持續增長也提供進一步支持。這樣的亮眼表現反映集團的線下及線上渠道銷售及營銷策略行之有效,從而把握品牌消費保健產品於香港、澳門及大灣區市場的增長潛力。董事會宣派中期股息每股5.50港仙,同比增長59.4%。各分部均錄得顯著增長品牌藥分部的銷售收益增長23.9%,主要受惠於何濟公產品持續的銷售勢頭。作為止痛退燒藥非處方類別中領先的家用品牌,何濟公透過精準品牌營銷及銷售計劃鞏固其市場佔有率。該品牌加強社交媒體運營,特別是在小紅書及抖音等平台上,以提高其對年輕群體的吸引力,順應數字化趨勢,並擴大其在中國內地年輕消費者當中的影響力。品牌中藥分部銷售收益增長17.9%,主要受保濟丸的強勁表現及濃縮中藥顆粒業務的持續增長所帶動。作為提升品牌知名度的持續策略其中一環,保濟丸在銷售高峰期間策略性地播出由知名歌手王菀之擔任品牌大使的電視廣告,以加深消費者的印象。此外,保濟丸亦成為熱門TVB節目《中年好聲音3》的冠名贊助商,向廣大電視觀眾進一步宣傳品牌。健康保健品分部的銷售收益增長38.9%。該增長主要受Oncotype DX安可待乳癌基因表現檢測 (“Oncotype DX”) 的穩步增長,加上集團擴大產品組合及加強針對大眾健康市場的營銷力度所帶動。Oncotype DX在香港及澳門的醫療專業人士中已獲得越來越高的認可度,特別是在公營界別。為進一步支持增長,集團與香港乳癌基金會合作推出一項患者護理計劃,向檢測結果顯示需要接受進一步化療的公立醫院病人提供費用報銷。擴展跨境電子商務及傳統中藥行業集團在拓展線上業務方面取得進展,尤其是跨境電子商務平台,同時策略性地進行部署,把握香港及大灣區持續增長的傳統中藥行業機遇。此外,集團就何濟公、保濟丸、濃縮中藥顆粒產品及雅各臣藥業在已於天貓國際開設旗艦店,以加強品牌知名度及擴大在中國內地的覆蓋範圍。此等措施顯著提升集團於內地消費者群中的品牌知名度及形象。健倍苗苗行政總裁黃一偉先生表示:「儘管報告期內零售環境充滿挑戰,該集團仍然通過豐富的產品組合、有效的品牌管理及強大的商業執行實現斐然成績,尤其是在我們的旗艦品牌方面取得了顯著成功。展望未來,我們對集團的策略定位持樂觀態度,並對持續增長充滿信心。多個主要市場因素,包括久坐的生活方式、生活水平提升帶來更高健康意識及人口老齡化,共同促進了消費者健康需求的增長動力。我們致力於卓越營運及增長策略,專注於豐富產品組合、加強商業能力以及擴大銷售平台及地理覆蓋範圍。」有關健倍苗苗(保健)有限公司 (股份代號:2161)健倍苗苗是設於香港的品牌醫療保健品推廣及分銷公司,產品據點遍及大中華、東南亞及其他選定國家。集團擁有豐富的行銷專業知識並具備深厚的製藥背景,秉承產品功效和品質至上的優良傳統,在行業內定位獨特,致力於滿足消費者的保健需要。作為本地領先的品牌醫療保健品運營商,集團擁有一廣泛系列品牌醫療保健品,包括品牌藥、品牌中藥及健康保健品,其中包括「保濟丸」、「何濟公止痛退熱散」、「德國秀碧除疤膏」、「美德瑪寶兒除疤啫喱」、「唐太宗活絡油」、「飛鷹活絡油」、「十靈丹」、「十靈油」及「鎮痛霸祛風活絡油」等家喻戶曉的傳統品牌。而自2021年 5月27日,集團獲納入 MSCI 香港微型股指數成份股。有關集團詳情,請瀏覽:www.jbmhealthcare.com.hk Copyright 2024 亞太商訊 via SeaPRwire.com.
More
第四範式前三季度平臺業務增長50.2% 超40款AI產品提供強增長動力 ACN Newswire

第四範式前三季度平臺業務增長50.2% 超40款AI產品提供強增長動力

香港, 2024年11月19日 - (亞太商訊 via SeaPRwire.com) - 北京第四範式智能技術股份有限公司(「第四範式」或「公司」,股份代號:6682.HK)發佈2024年截至9月30日期間核心業務進展,今年前三季度營收人民幣32.18億元,同比增長26.1%;毛利人民幣13.50億元,同比增長12.5%。公司核心業務先知AI平台業務顯著增長,收入人民幣21.71億元,同比增長50.2%。據國際權威研究機構國際數據公司(「IDC」)報告數據顯示,第四範式連續六年穩居中國機器學習平台市場份額第一。公司持續優化先知AI平台中AI Agent、GPU資源池化等多項關鍵能力,已實現算力層、平台層、模型層、應用層等端到端的能力供給。並通過「先知 Inside 模式」,高效打造了40餘款人工智能產品矩陣,極大拓展產業生態及人工智能賦能千行萬業的應用邊界。前三季度第四範式客戶服務深度和用戶粘性不斷提升,繼續深耕交通運輸、能源電力、金融、運營商等重點行業,期間企業總用戶數224個,標杆用戶群體平均營收貢獻為人民幣1,487萬元(標杆用戶:全球財富500強企業或上市公司)。核心業務增長50.2%,「先知Inside模式」40款AI產品為長期增長提供動力第四范式先知AI平台,是公司所有業務的內核。前三季度,第四範式行業大模型開發及管理平台「先知AI平台5.0」已實現算力層、平台層、模型層、應用層等端到端的能力供給。先知AI平台持續優化其AI Agent、GPU資源池化、模型統一納管等多項關鍵能力,同時開展生成式AI與各類生態產品、解決方案的深度結合,推動生成式AI落地進程。例如,AI Agent 提升了複雜推理及執行的精准度,並覆蓋大模型Agent設計、開發、調試、發佈、運營分析、自學習優化的全流程,為Agent生產應用提供穩定可靠保障;此外,公司也進一步提升AI Coding類產品在企業側產品功能及應用效果,降低開發門檻、提升代碼開發效率,實現了改造企業軟件交互方式、及規模化打造AI應用的目標。公司繼續創新AI商業應用模式,通過「先知Inside模式」,規模化構建可應用不同場景的人工智能產品,截至2024年9月30日,在該模式下,公司已累計打造40餘款人工智能產品,囊括智慧滑鼠解決方案、智能會議解決方案、vGPU、AI Data Foundry、大模型工具鏈、搜廣推一體化平台「天樞」、大模型納管平台Model Hub、智慧問數、AI數位人視頻合成平台、文檔數字化管理平台Smart Archive 2.0、AI+5G視頻营銷、AI質檢系統、三維掃描建模設備等多款人工智能產品,在企業中形成了規模化應用,拓寬先知AI平臺的行業覆蓋空間,為公司未來業務發展提供長期增長動力。AI Agent賦能多款解決方案,規模化打造標杆意義行業大模型本期間,第四範式進一步拓展技術、產品在多行業及場景的覆蓋度及滲透率。在產品功能迭代方面,公司將AI Agent能力加入到AIGS Builder、AIGS CodeX、及多款智能硬體解決方案中,讓產品獲得解決更加複雜的推理和執行能力。且基於強化學習技術的AI Agent形成了自學習閉環,用戶使用越多,模型推理能力越強,執行能力越準確。本期間,公司攜手標杆用戶聯合打造了一批具有示範意義的行業大模型,並加速推動人工智能技術在千行百業的規模化應用。在交通運輸領域,與全球領先的港口集團合作構建港口供應鏈大模型,為實現港口供應鏈綜合服務轉型提供智能化能力輸出,推動大模型在港航領域及周邊業態的可持續應用發展;在學術翻譯領域,公司與現代出版機構合作共建國內首個出版專業大模型,使大模型的翻譯水準達到學術出版級別,較通用大模型在專業書籍的 BLEU(BLEU:機器翻譯的主流評估標準,主要通過對比機器翻譯結果與人工參考翻譯之間的相似度來評價翻譯質量)提升 30% 以上,滿足學術垂直領域的高準確度翻譯需求。 Copyright 2024 亞太商訊 via SeaPRwire.com.
More

可持續內生增長 晶科電子處價值窪地

香港, 2024年11月19日 - (亞太商訊 via SeaPRwire.com) - 伴隨四季度港股IPO市場景氣度回升,年度 「超購王」晶科電子(2551.HK)的憑藉驚豔表現,成為市場矚目的焦點。高達5,678倍的公開發售認購倍數,不僅打破了科技類企業港股IPO的歷史記錄,也讓公司成為港股IPO史上僅次於毛記葵湧的唯二超過5,000倍的新股。目前晶科電子股價位於4元區間,仍處價值窪地,看漲未來長期估值。根據公司招股書,未來三年,公司也擬根據業務運營及現金流量狀況採用不低於派息年度淨利30%的派息率,該派息政策可見公司對於自身盈利能力和可持續發展的信心,進一步奠定了投資者長期持有公司標的的信心。同時,公司能夠獲得資本市場青睞,與晶科電子領先的行業地位、穩健的基本面及遠闊的發展前景密不可分。作為LED智能視覺行業頭部企業,公司深入佈局高成長性確定性強的優質賽道,技術能力位於全球創新先進行列,在汽車智能視覺、高端照明及新型顯示三大高增長的LED細分市場,顯現出加速兌現的態勢。當前國家以舊換新家電、汽車等政策性補貼加碼,全國相關消費熱度維持高水平。市場對新型顯示的需求顯著增加,晶科電子産能全滿,業績額有足夠市場支撐。據市場消息,10月晶科電子在汽車智能視覺領域的銷售額或將創下新紀錄。「LED+」技術賦能,高築競爭壁壘受益於LED技術進步及LED產品廣泛應用,LED智能視覺行業已逐步向「LED+」技術的轉變。「LED+」技術將LED技術與電子控制、軟件、傳感器及光學等相結合,為行業發展設定了新軌跡。根據廣東省照明學會的資料,「LED+」技術已成為行業規範,被行業廣泛採用,並受機構及實體廣泛引用。利用在LED晶片和封裝技術方面的前期積累及成就,晶科電子開發出廣泛的技術。公司的技術包括涵蓋倒裝LED技術及先進光電半導體封裝技術的基礎技術,及針對特定應用領域而開發的特定產品技術。基於獨具優勢的專有技術,公司持續加強自主研發,形成了一套全面的知識產權保護體系。截至最後實際可行日期,公司在多個國家擁有376項專利,研發成果豐碩。基礎技術方面,晶科電子是早期從事倒裝LED技術開發的領先公司之一,其基於倒裝晶片結構的LED產品,具有熱傳導能力強、耐用性高、可靠性好及光效高的優勢,在行業內始終表現出卓越的性能、高生產良率及高質量。同時,公司掌握多種先進光電半導體封裝技術的核心技術,其中包括先進白光封裝光轉換技術、先進LED集成封裝技術及高端LED器件封裝技術。針對特定產品的技術方面,於過去幾年,晶科電子以先進的基礎技術為依託,專注於LED應用關鍵技術的開發,涵蓋汽車智能視覺、高端照明及新型顯示。由此,公司成功開發了針對智能車燈、車規級LED器件和模組、高端LED照明及新型顯示的多種針對特定產品的技術。後續,晶科電子將專注「LED+」創新,實現技術突破。一方面,持續構建「LED+」核心技術體系,加速前沿技術研發,保持技術先進性。另一方面,將預判市場需求顯現節奏,戰略性佈局傳感器、激光雷達、控制器技術,加大對前沿技術和產品的持續研發投入,強化競爭優勢。一流客戶群助力業務擴張,汽車智能視覺或創新高由於車規級器件、模組以及汽車視覺產品及系統的技術開發要求嚴苛、設備投資巨大且體系認證門檻較高,汽車智能視覺市場具有較高進入門檻。已經在行業站穩腳跟的晶科電子,憑藉卓越的研發實力及穩定的產品質量,形成了穩定客戶群。近日,晶科電子獲三星電子面向全球合作夥伴頒發的「最佳外駐社」稱號及榮獲海信授予的「品質改進獎」等。這些獎項充分肯定了晶科電子在2024年度支持客戶業務發展中的突出表現和卓越貢獻,不僅彰顯了晶科電子專業高效的客戶服務支持能力,更體現了晶科電子爲客戶持續創造顯著價值的實力。業界的良好聲譽和知名度加持下,晶科電子穩步擴大業務規模,與客戶構建了長期合作關係。公司的客戶及終端用戶包括昕諾飛(曾用名飛利浦照明)、三星、松下、豐田合成等國際一線照明公司,以及海信、TCL、創維、長虹、LG及三星等知名電視品牌。此外,公司已與二十餘家國內汽車主機廠、汽車品牌及一級供應商建立合作關係,包括吉利汽車、領克、極氪、精靈、路特斯、廣汽、長安汽車、理想汽車等行業領導者。隨着客戶群的不斷擴張,近年來,晶科電子業績節節攀升,實現量與質的雙重提升。自2021年至2023年,公司收入從人民幣13.88億元增至18.58億元,複合年增長率為15.7%;毛利潤從人民幣2.28億元增至3.39億元,複合年增長率為21.9%。2024年前五個月,公司收入、毛利潤及經調整淨利潤分別同比增長35.0%、47.9%及465.3%,優秀盈利能力支撐業績高成長。消費者節能環保意識的提高,以及利好政策和法規的實施,推動LED智能視覺成為全球各國戰略性新興產業之一。根據灼識諮詢預計,全球LED智能視覺行業的市場規模到2028年將增長至2,872億美元,2023年至2028年的複合年增長率為8.4%。中國擁有全球最大的LED智能視覺產業,預計於2028年,該市場收入將達到人民幣6,792億元,2023年至2028年的複合年增長率為9.1%。高價值、高增長的LED智能視覺行業,孕育著無限的潛力和機遇。汽車智能視覺、高端照明及新型顯示正是行業中尚未飽和且最具潛力的市場,堪稱最具貝塔效應的黃金賽道。基本面與貝塔的共振,將最大化地釋放阿爾法效應,為晶科電子帶來高確定性的內生增長,短期股價波動無法影響其市場預期。晶科電子將以穿越週期之力,踐行長期主義的精髓。 Copyright 2024 亞太商訊 via SeaPRwire.com.
More

雲頂新耀宣佈耐賦康(R)在韓國獲批 商業化進程再創里程碑

香港, 2024年11月19日 - (亞太商訊 via SeaPRwire.com) - 雲頂新耀(HKEX 1952.HK)宣佈,韓國食品藥品安全部(MFDS)已正式完全批准耐耐賦康(R)(布地奈德腸溶膠囊)的新藥上市許可申請,用於治療罹患原發性免疫球蛋白A腎病變(IgAN)的成人患者(尿蛋白≥1.0g/日或尿蛋白與肌酐比 (UPCR) ≥0.8g/g)。這一批准標誌著耐賦康(R)進一步擴大了其在亞洲的市場覆蓋範圍,並為亞洲IgAN患者提供了創新的對因治療方案。對此,雲頂新耀首席執行官羅永慶表示,非常高興看到耐賦康(R)在韓國獲得完全批准。他指出,"作為全球首個且唯一獲得美國食品藥品監督管理局(FDA)完全批准的IgA腎病對因治療藥物,耐賦康(R)將為韓國的IgA腎病患者提供全新的對因治療選擇。我們將繼續努力推動耐賦康(R)在亞洲地區的可及性和可負擔性,滿足更多IgA腎病患者對此創新療法的迫切需求。"作為全球首個獲得完全批准的IgA腎病對因治療藥物,耐賦康(R)的臨床價值已在國際醫學界得到廣泛認可。此次韓國獲批基於全球III期臨床試驗NefIgArd研究數據。研究結果顯示,與安慰劑相比,耐賦康(R)在多項臨床指標上表現出顯著優勢,包括持久降低蛋白尿下降,減少鏡下血尿風險,並在估算腎小球濾過率(eGFR)上顯示出臨床相關且有統計學意義的治療獲益(p
More
GTDC 高峰會亞太區亮點:IT 經銷商在數位轉型中的角色 ACN Newswire

GTDC 高峰會亞太區亮點:IT 經銷商在數位轉型中的角色

新加坡, 2024年11月19日 - (亞太商訊 via SeaPRwire.com) - 今天,IT 分銷和科技供應商領域的頂級高管齊聚首屆 GTDC 亞太峰會 2024,探討這些關鍵領域的當前狀況和未來前景。此次高峰會強調了經銷商在擴展新興技術銷售和採用方面的重要作用,以及透過數位市場和與超大規模服務商的聯盟創造新機會的必要性。Frank Vitagliano 在首届 GTDC 亚太峰会开幕式上强调了分销价值的日益提升。亞太區的廣闊規模和經濟、文化多樣性需要本地專業知識。隨著供應商採用不同的方法來管理通路,他們越來越依賴經銷商來支援新興市場,同時將內部資源集中在更成熟的市場。這項策略拓寬了分銷的覆蓋面,特別是在直接覆蓋效率較低的地區,並代表著透過合作夥伴關係優化資源協調的更廣泛趨勢。「經銷商處於理想的位置,可以彌合複雜的區域和國家間的動態,利用本地代表的文化和語言敏銳度來最好地支持供應商和合作夥伴的目標。專注於賦能計劃和關係建設,經銷商能夠創造戰略價值,確保先進技術在亞太地區的成功應用,」GTDC 執行長Frank Vitagliano 表示。東南亞和印度的 IT 支出正在加速成長,中小企業透過雲端軟體、網路安全和物流投資來推動數位轉型。這種數位化轉型帶來了對雲端基礎架構、託管服務和強大安全解決方案的更高需求。同時,根據 IDC 的數據,人工智慧的採用進一步推動了該地區的技術勢頭,預計到 2027 年該領域的支出將達到 780 億美元,年增長率為 25%。經銷商在推動這些技術進步的同時,改善了客戶體驗,並提高了這些關鍵領域的營運效率。在該地區人才短缺尤其嚴重的關鍵領域,如 AI、銷售和技術支援方面,供應商也依賴經銷商來滿足日益增長的需求。分銷商在滿足這些需求的同時,透過先進的數據分析技術解鎖了新的機會。 Channelnomics 的執行長 Larry Walsh 強調了這些組織在識別「空白市場」和擴展合作夥伴網路方面的能力。他指出:「雖然數據提供了方向,但其真正的價值在於將洞察轉化為合作夥伴的可執行策略。經銷商在重新定義市場進入模式方面發揮了關鍵作用,引導合作夥伴進行能夠增強業務的互動,並最大化通路潛力。亞太峰會的其他精彩亮點高峰會重點探討了 IT 分銷的動態變化,並強調了東南亞和印度在全球科技產業中的日益重要性。主要議程包括:EIU 的 John Marrett 發表了關於快速擴展的市場的演講,描述了技術創新如何改變企業和社區。他深入分析了貨幣和財政政策的變化、匯率波動及國際金融機構的活動對亞太區 IT 社群的影響。IDC 的 Avneesh Saxena 展示了創新如何影響全球 IT 關係並為通路創造新的機會。他強調了關鍵產業趨勢、障礙和投資情況,並探討了合作夥伴、供應商和經銷商之間不斷發展的動態關係。Channelnomics 的 Larry Walsh 分析了供應商與經銷商關係中常被忽視的要素,並分享了他們與 GTDC 合作發布的新研究的關鍵發現。該報告聚焦於亞太地區,向供應商展示如何最大化分銷關係的價值。Vitagliano 主持了一個高級分銷高管小組討論,參與者包括 VST ECS 的 William Ong、Redington Limited 的 V.S. Hariharan、Ingram Micro 的 Luis Lourenco、TD SYNNEX 的 Jaideep Malhotra 和 Westcon-Comstor 的 Patrick Aronson。小組成員重點介紹了區域分銷商如何創新,創建推動新技術應用的項目,優化市場進入策略並增強其他業務活動。下一場 GTDC 全球活動是 GTDC 北美高峰會,將於 2025 年 2 月 19 日至 20 日在加州奧申賽德的 Mission Pacific & Seabird Resort 舉行。更多詳細資訊將很快公佈。關於 GTDC全球技術分銷委員會 (GTDC) 是一個行業聯盟,代表了全球領先的科技經銷商。 GTDC 成員透過多樣化的業務管道推動全球產品、服務和解決方案的年銷售額約 1,600 億美元。 GTDC 會議支援策略供應鏈合作夥伴關係的發展和擴展,不斷滿足供應商、終端客戶和經銷商在快速變化的市場中的需求。GTDC 成員包括AB S.A (華沙證券交易所: ABPL)、Arrow Electronics (NYSE: ARW)、CMS Distribution、Computer Gross Italia (米蘭證券交易所: SES)、D&H Distributing、ELKO、Esprinet (米蘭證券交易所所: PRT.MI)、Exclusive Networks (巴黎證券交易所: EXN)、Exertis、Infinigate、Ingram Micro (NYSE: INGM)、Intcomex、Logicom (塞浦路斯證券交易所: LOG)、Mindware、Redington Limited (孟買/國家證券交易所: Redington)、Siewert & Kau、SiS Technologies (香港證券交易所: 0529)、Tarsus、TD SYNNEX (NYSE: SNX)、TIM AG、VSTECS Holdings 和Westcon-Comstor。GTDC 媒體聯絡方式:Anita LussenburgTel +31621585878Mail: alussenburg@gtdc.eu資料來源: Global Technology Distribution Council Copyright 2024 亞太商訊 via SeaPRwire.com.
More
GMG Reaches Market Commercialisation Milestone on Energy Savings Coating THERMAL-XR(R) ACN Newswire

GMG Reaches Market Commercialisation Milestone on Energy Savings Coating THERMAL-XR(R)

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - November 19, 2024) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to provide a business update on the commercialisation progress of THERMAL-XR® Powered by GMG Graphene.SINGAPORE GREEN BUILDING COUNCIL PRODUCT APPROVALThe Singapore Green Building Council has approved THERMAL-XR to be certified as a Singapore Green Building Product (SGBP) under the category of Mechanical - ACMV - Coil Coating. It is the first thermal air conditioning coating to be approved as a SGBP - please see the attached link: https://web.sgbc.online/public/product/certificate/5/46/495/8867/2978.The SGBP Certification Scheme is one of the key standards and benchmarks for green building products in the building and construction industry. Products and materials certified as a SGBP are highly recognised under the Green Mark Certification Scheme, Singapore's national green building rating tool administered by the Building and Construction Authority (BCA), which allows certified products to accrue points that count towards a project's Green Mark rating. The more highly rated a product is under the SGBP Certification Scheme (i.e., the more ticks it has achieved), the more points are awarded towards the Green Mark rating.The SGBP Certification Scheme is also widely accepted by regional green building rating tools for its coverage of products' sustainability performance. Examples include GreenRE, a rating tool set up by the Real Estate & Housing Developments' Association (REHDA) of Malaysia, and LOTUS, Vietnam Green Building Council's rating tool. The SGBP Certification Scheme complies with many of the requirements in ISO 14024 Environmental labels and declarations - Type I environmental labelling.Figure 1To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8082/230564_97152fedf493f854_001full.jpgThe benefits of SGBP Certification include:FOR PRODUCT SUPPLIERS:Analysis of your product's sustainability performance by experts and certification by a credible sourceOpportunity and insight into how to further develop your products to be more sustainableGreater awareness of your product for use in our current and future buildingsFOR DESIGNERS/ SPECIFIERS:An overview of products that are certified sustainableAn understanding of how a product stacks up against others in terms of their sustainability performanceEasier decision-making when choosing more sustainable productsFOR BUILDERS/ OWNERS:An overview of products that are certified sustainableData around the environmental properties of the products you useA unique selling point for your building projectsFOR TENANTS/ OCCUPANTS:An understanding of how sustainable the spaces you live and work in areHealth benefits of living/working in a greener buildingOnce a product is certified, SGBC will issue the product a certificate. Only certified products will be listed on the SGBP Certification Directory, which is maintained on the Singapore Green Building Council's website. This Interactive Directory is actively used by building industry professionals such as consultants, contractors, building developers and owners. Stakeholders can demand that products/ materials used for a building are SGBP certified. Certified products can gain credits under various green building rating tools.USA EPA PRE-MANUFACTURE NOTICE SUBMISSION MADEGMG and Nu Calgon have submitted a Pre-Manufacture Notice ("PMN") in conjunction with its USA Environmental Protection Agency's ("EPA") application to import and sell THERMAL-XR® in the USA. The PMN application is expected to be approved in less than 12 months. The PMN application covers the use of the coating in various application methods in various industrial applications.GMG's Managing Director and CEO, Craig Nicol, commented: "The SGBP Certification is highly welcomed and comes after many years of working with our coating and carrying out many demonstration projects in Singapore with our distribution and coating partners. We also welcome the progress on the EPA submission with our Nu Calgon distribution partner."GMG's Chairman and Director, Jack Perkowski, commented: "THERMAL-XR® being recognised as a Singapore Green Building Product is a very good sign of all the hard work GMG has done there over the years. The USA HVAC after market for coatings is a substantial opportunity for GMG and so it is good to see the progress on the EPA submission as well."About THERMAL-XR® powered by GMG Graphene:THERMAL-XR® COATING SYSTEM is a unique method of improving the conductivity of corroded heat exchange surfaces and improving and maintaining the performance of new units at peak levels. The process coats and protects heat exchange surfaces while improving and rebuilding the lost corroded thermal conductivity and increasing the heat transfer rate by leveraging the physics of GMG Graphene, resulting in an efficiency improvement and a potential power reduction.THERMAL-XR RESTORE® is powered by GMG Graphene. PATENT PENDINGAbout GMG www.graphenemg.comGMG is a clean-technology company which seeks to offer energy saving and energy storage solutions, enabled by graphene, including that manufactured in-house via a proprietary production process. GMG has developed a proprietary production process to decompose natural gas (i.e. methane) into its elements, carbon (as graphene), hydrogen and some residual hydrocarbon gases. This process produces high quality, low cost, scalable, 'tuneable' and low/no contaminant graphene suitable for use in clean-technology and other applications.The Company's present focus is to de-risk and develop commercial scale-up capabilities, and secure market applications. In the energy savings segment, GMG has focused on graphene enhanced heating, ventilation and air conditioning ("HVAC-R") coating (or energy-saving coating), lubricants and fluids.In the energy storage segment, GMG and the University of Queensland are working collaboratively with financial support from the Australian Government to progress R&D and commercialization of graphene aluminium-ion batteries ("G+AI Batteries").GMG's 4 critical business objectives are:Produce Graphene and improve/scale cell production processesBuild Revenue from Energy Savings ProductsDevelop Next-Generation BatteryDevelop Supply Chain, Partners & Project Execution CapabilityFor further information please contact:Craig Nicol, Chief Executive Officer & Managing Director of the Company at craig.nicol@graphenemg.com, +61 415 445 223Leo Karabelas at Focus Communications Investor Relations, leo@fcir.ca, +1 647 689 6041Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking Statements This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends", "expects" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or will "potentially" or "likely" occur. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, the receipt, timing and nature of approval by the EPA of the PMN application and the opportunity represented by the USA HVAC after market for coatings. Such forward-looking statements are based on a number of assumptions of management, including, without limitation, assumptions regarding that the EPA will approve the PMN application and on the timing anticipated, that the content of the EPA's approval will be as anticipated, and that the USA HVAC after market for coatings is a substantial opportunity for the Company. Additionally, forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of GMG to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: that the EPA will not approve the PMN application on the timing anticipated or at all, that the content of the EPA's approval will not be as anticipated, that the USA HVAC after market for coatings is not a substantial opportunity for the Company, risks relating to the extent and duration of the conflict in Eastern Europe and its impact on global markets, the volatility of global capital markets, political instability, the failure of the Company to obtain regulatory approvals, attract and retain skilled personnel, unexpected development and production challenges, unanticipated costs and the risk factors set out under the heading "Risk Factors" in the Company's annual information form dated October 3, 2024 available for review on the Company's profile at www.sedarplus.ca.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/230564 Copyright 2024 ACN Newswire via SeaPRwire.com.
More
JBM Healthcare Announces FY2025 Interim Results ACN Newswire

JBM Healthcare Announces FY2025 Interim Results

KEY HIGHLIGHTS- Revenue up by 22.1% to HK$399.0 million- Gross profit increased by 20.3% to HK$205.9 million- Consolidated profit attributable to equity shareholders grew by 53.4% to HK$95.9 million- Interim dividend of HK5.50 cents per share, up by 59.4% year-on-year- Flagship proprietary brands Ho Chai Kung and Po Chai Pills achieved robust growth through effective integrated sales and marketing strategies- Concentrated Chinese medicine granules (“CCMG”) business displayed solid growth momentum, contributing to operational performanceHONG KONG, Nov 19, 2024 - (ACN Newswire via SeaPRwire.com) - JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the interim results of the Group for the six months ended 30 September 2024 ("FY2025 Interim" or the "Reporting Period").During the Reporting Period, the Group's branded healthcare business delivered exceptional performance. Revenue reached HK$399.0 million, representing a notable period-on-period growth of 22.1%. The Group's gross profit for the same period reached HK$205.9 million, representing an increase of 20.3%. In the first half of fiscal year 2025, the consolidated profit attributable to equity shareholders grew by 53.4% to HK$95.9 million.The Group's robust performance was propelled by the outstanding sales from flagship brands, with Ho Chai Kung leading in branded medicines and Po Chai Pills excelling in proprietary Chinese medicines. Additionally, the CCMG business of the Group sustained solid growth momentum. These results reflect the successful execution of integrated sales and marketing strategies across both offline and online channels, effectively capitalising on expanding demand for consumer healthcare products in Hong Kong, Macau, and Greater Bay Area.The Board has declared the payment of an interim dividend of HK5.50 cents per share, up by 59.4% year-on-year.Notable Growth Across SegmentsIn the branded medicines business, sales revenue grew by 23.9%, which was led by sustained momentum in Ho Chai Kung product sales. As a leading household name in over-the-counter pain relief and fever medications, Ho Chai Kung strengthened its market presence through targeted brand marketing and sales initiatives. The brand enhanced its appeal to young consumers by ramping up its social media efforts, particularly on platforms like Xiaohongshu and Douyin, aligning with digital trends and expanding its reach among Mainland Chinese youth.In the proprietary Chinese medicines segment, sales rose 17.9%, driven by the strong performance of Po Chai Pills and the sustained growth of the CCMG business. As part of its ongoing strategy to boost brand awareness, Po Chai Pills strategically aired its TV commercial featuring renowned singer Ivana Wong as a brand ambassador during peak sales periods to enhance consumer recall. Additionally, Po Chai Pills gained further visibility by title-sponsoring the popular TVB program "Midlife Sing & Shine! 3", reaching a broad television audience.In the health and wellness products segment, sales revenue increased by 38.9%, driven by the steady growth of Oncotype DX Breast Cancer Recurrence Score Test (“Oncotype DX”), along with expanded product offerings and enhanced marketing efforts targeting the mass wellness market. Oncotype DX has gained increasing recognition among healthcare professionals in Hong Kong and Macau, particularly in the public sector. To further support growth, the Group launched a patient care program with the Hong Kong Breast Cancer Foundation, enabling public hospital patients to receive reimbursement for the test if it indicates the need for additional chemotherapy.Cross-Border E-Commerce and TCM Sector ExpansionThe Group has made positive strides in expanding its online presence, particularly on cross-border e-commerce platforms, while strategically positioning itself to capitalise on the growing traditional Chinese medicine ("TCM") sector in Hong Kong and the Greater Bay Area. Flagship stores for Ho Chai Kung, Po Chai Pills, CCMG, and Jacobson Medical have been launched on the Tmall Global, strengthening brand presence and extending reach in Mainland China. These initiatives have significantly enhanced brand visibility and image among Mainland Chinese consumers.Mr. Patrick Wong, Chief Executive Officer of JBM Healthcare, commented, "Despite a challenging retail environment during the Reporting Period, the Group delivered strong performance driven by our robust portfolio, effective brand management, and enhanced commercial execution, with particular success in our flagship proprietary brands.""Looking ahead, we remain optimistic and confident in the Group's strategic positioning for sustained growth. Key market dynamics, including sedentary lifestyles, increasing health consciousness driven by improving living standards, and aging populations, are collectively fueling growth momentum in consumer healthcare demand. We are committed to operational excellence and growth strategies that focus on enriching our product portfolio, strengthening commercial capabilities, and broadening our sales platforms and geographic reach."About JBM (Healthcare) Limited (Stock Code: 2161)JBM Healthcare is a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia, and other select countries. The Group is a distinctive player in the sector with marketing expertise and heritage in pharmaceuticals that prioritises product efficacy and quality to meet consumers' healthcare needs. As a renowned healthcare brand operator in Hong Kong, the Group carries a wide-ranging portfolio of branded healthcare products comprising branded medicines, proprietary Chinese medicines, and health and wellness products, which include well-recognised household brands such as Po Chai Pills, Ho Chai Kung Tji Thung San, Contractubex, Mederma for Kids, Tong Tai Chung Woodlok Oil, Flying Eagle Woodlok Oil, Saplingtan, Shiling Oil and Konsodona Medicated Oil. JBM Healthcare has been a constituent stock of the MSCI Hong Kong Micro Cap Index since 27 May 2021. For more details about JBM Healthcare, please visit: www.jbmhealthcare.com.hk Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Fourth Paradigm’s Platform Business Grew by 50.2% in the First Three Quarters ACN Newswire

Fourth Paradigm’s Platform Business Grew by 50.2% in the First Three Quarters

HONG KONG, Nov 19, 2024 - (ACN Newswire via SeaPRwire.com) - Beijing Fourth Paradigm Technology Co., Ltd. (“Fourth Paradigm” or the “Company”, Stock Code: 6682.HK) announced its core business update for the period ended September 30, 2024. The Company achieved a revenue of RMB3.2 billion in the first three quarters of this year, marking a 26.1% year-on-year increase. The gross profit reached RMB1.4 billion, showing a 12.5% year-on-year growth.The company's core business, the Sage AI platform, has shown significant growth, generating a revenue of RMB2.2 billion, representing a year-on-year increase of 50.2%. According to data from International Data Corporation (IDC), a reputable international research institution, Fourth Paradigm has consistently ranked first in the machine learning platform sector in China in terms of market share for six consecutive years.The Company continues to enhance key capabilities within the Sage AI platform, such as AI Agent and GPU resource pooling, and has successfully achieved end-to-end capabilities in computing power, platform infrastructure, model development, and application deployment. Through the "Sage Inside" model, Fourth Paradigm has efficiently developed over 40 artificial intelligence products, significantly expanding the boundaries of industrial ecosystems and empowering various industries with artificial intelligence applications.In the first three quarters, Fourth Paradigm has seen a continual improvement in customer service depth and user engagement. The Company has focused on industries such as transportation, energy and power, finance, and telecommunications, with a total of 224 corporate users, including 98 lighthouse users. On average, lighthouse users, namely Global Fortune 500 companies and publicly listed companies, contribute approximately RMB14.9 million in revenue.The core business grew by 50.2%, with the "Sage Inside" model and 40 AI products driving long-term growthThe Fourth Paradigm Sage AI platform serves as the nucleus of all operations of the Company. In the first three quarters, the industry-leading large model development and management platform, "Sage AI Platform 5.0", has achieved end-to-end capabilities in computing power, platform infrastructure, model development, and application deployment. The AI platform continues to optimize key capabilities such as AI Agents, GPU resource pooling, and unified model hosting. It also integrates generative AI with various ecosystem products and solutions to advance the deployment of generative AI.For instance, AI Agent has enhanced the precision of complex reasoning and execution, covering the entire lifecycle from large model Agent design, development, commissioning, deployment, operational analysis, to self-learning optimization, providing a stable and reliable support for Agent production applications. Additionally, the Company has further improved AI Coding products in terms of enterprise-side product functionality and application effectiveness, thus reducing development barriers, enhancing code development efficiency, and transforming enterprise software interaction methods to scale up AI application development.The Company continues to innovate AI business application models, scaling the construction of AI products applicable to various scenarios through the "Sage Inside" model. As of September 30, 2024, under this model, the Company has developed over 40 AI products, including solutions like intelligent mouse solution, intelligent meeting solution, vGPU, AI Data Foundry, large model toolchains, the integrated platform "Tianshu" for search, advertising and promotion, Model Hub for large model hosting, intelligent number query, AI digital human video generation platform, Smart Archive 2.0 for document digitization management, AI+5G video marketing, AI quality inspection systems, 3D scanning and modeling devices, and many more. These AI products have been widely applied in enterprises, expanding the industry coverage of the Sage AI platform and providing long-term growth impetus for the Company's future business development.AI Agent empowers multiple solutions, scaling the development of industry large models with demonstrative significanceDuring the period, Fourth Paradigm further expanded the coverage and penetration of its technology and products across multiple industries and scenarios. In terms of product feature iterations, the Company integrated AI Agent capabilities into AIGS Builder, AIGS CodeX, and various intelligent hardware solutions, enabling products to achieve more complex reasoning and execution capabilities. Moreover, the AI Agent based on reinforcement learning technology has formed a self-learning loop, where the more users engage with it, the stronger the model's reasoning and execution capabilities become.During the period, the Company collaborated with lighthouse users to jointly create a set of industry-leading large models with demonstrative significance, accelerating the widespread application of AI technology across various industries.In the field of transportation, the Company partnered with a globally leading port group to build a large model for port supply chain management, providing intelligent capabilities for the transformation of comprehensive port supply chain services and promoting sustainable applications of large models in the port and maritime industries and related businesses. For academic translation, the Company collaborated with Modern Press to establish the first professional publishing large model in China, elevating the translation quality of large models to academic publication standards. Compared to general-purpose large models in professional book translations, this large model showed an improvement of over 30% in BLEU (BLEU: a mainstream evaluation standard for machine translation, primarily assessing translation quality by comparing the similarity between machine-translated results and human reference translations), meeting the high-accuracy translation demands of academic verticals. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
GTDC Summit APJ Highlights IT Distributors’ Roles in Navigating Digital Transformation ACN Newswire

GTDC Summit APJ Highlights IT Distributors’ Roles in Navigating Digital Transformation

SINGAPORE, Nov 19, 2024 - (ACN Newswire via SeaPRwire.com) - Top executives from the IT distribution and technology vendor sectors convened today at the inaugural GTDC APJ-Summit 2024 to discuss the current position and future outlook of these critical communities. The Summit underscored the essential role distributors play in scaling emerging technology sales and adoption and developing new opportunities through digital marketplaces and alliances with hyperscalers.Frank Vitagliano emphasizes the rising value of distribution as he opens the inaugural GTDC Summit APJ.The vast scale and economic and cultural diversity of the APJ region necessitates local expertise. As vendors adopt varied approaches to managing channels, they are increasingly relying on distributors to support emerging markets while focusing internal resources on more mature communities. This strategy provides greater reach, especially in areas where direct coverage would be inefficient, and represents a broader shift towards optimizing orchestration through partnerships."Distributors are ideally positioned to bridge complex regional and in-country dynamics, with local representatives who understand cultural and language nuances to best support the objectives of their vendors and partners. Focusing on enablement programs and relationship-building allows distributors to create strategic value that ensures the successful adoption of advanced technologies across diverse APAC markets," said Frank Vitagliano, CEO, GTDC.IT spending across Southeast Asia and India is accelerating, driven by SMBs embracing digital transformation through cloud software, cybersecurity, and logistics investments. This digital shift generates increased demand for cloud infrastructure, managed services, and robust security solutions. Simultaneously, according to IDC, AI adoption is further fueling the region's technological momentum, with spending in this area expected to reach $78 billion by 2027, with a 25% annual growth rate. Distributors empower those advances while transforming the customer experience and operational efficiencies across these key sectors.Vendors also rely on distributors to meet the rising demand for AI, sales, and technical support as the region struggles with talent shortages, especially in these key areas.Distributors are meeting these demands while unlocking new opportunities using advanced data analytics. Channelnomics CEO Larry Walsh emphasized these organizations' capabilities for identifying "white space" and expanding partner networks. "While data provides direction, its true value lies in transforming insights into actionable strategies for partners. Distributors are pivotal in redefining go-to-market models, guiding partners through business-enhancing engagements and maximizing channel potential."Other Memorable Highlights from Summit APJThe summit focused on the changing dynamics of IT distribution, emphasizing the increasing importance of Southeast Asia and India in the global tech sector. Key sessions included:John Marrett from the EIU spoke to the rapidly expanding marketplace and described the ways technical innovation is changing businesses and communities. From shifts in monetary and fiscal policies to currency fluctuations and international financial institutions' activities, he highlighted the impact of these movements on the APJ's IT community.Avneesh Saxena of IDC showed how innovation affects global IT relationships and creates new opportunities for the channel. He emphasized the key industry trends, barriers, and investments and explored the evolving dynamics between partners, vendors, and distributors.Larry Walsh of Channelnomics examined the often-overlooked pieces of the vendor-distributor relationship and hit on other key findings of their recently released study with GTDC. Focused on the Asia-Pacific region, the new report shows vendors how to maximize the value of their distribution relationships.Vitagliano also moderated a panel discussion with senior distribution executives, including William Ong,VST ECS;V.S. Hariharan, Redington Limited; Luis Lourenco, Ingram Micro; Jaideep Malhotra, TD SYNNEX; and Patrick Aronson, Westcon-Comstor. Panelists highlighted how regional distributors are innovating and creating programs that facilitate the adoption of new technologies, optimize go-to-market strategies and enhance other business activities.The council's next global event GTDC Summit North America, February 19th -20th, 2025, at the Mission Pacific & Seabird Resort in Oceanside, CA. More details will be available soon.About the GTDC The Global Technology Distribution Council is the industry consortium representing the world's leading tech distributors. GTDC members drive an estimated $160 billion in annual worldwide sales of products, services and solutions through diverse business channels. GTDC conferences support the development and expansion of strategic supply-chain partnerships that continually address the fast-changing marketplace needs of vendors, end customers and distributors. GTDC members include AB S.A (WSE: ABPL), Arrow Electronics (NYSE: ARW), CMS Distribution, Computer Gross Italia (MI: SES), D&H Distributing, ELKO, Esprinet (PRT.MI), Exclusive Networks (EPA: EXN), Exertis, Infinigate, Ingram Micro (NYSE: INGM), Intcomex, Logicom (CSE: LOG), Mindware, Redington Limited (BSE/NSE: Redington), Siewert & Kau, SiS Technologies (HKSE:0529), Tarsus, TD SYNNEX (NYSE: SNX), TIM AG, VSTECS Holdings and Westcon-Comstor.GTDC MEDIA CONTACT: Anita LussenburgTel +31621585878Mail: alussenburg@gtdc.euSOURCE: Global Technology Distribution Council Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Beat The Silent Disease of Osteoporosis with LAC, Before It’s Too Late! ACN Newswire

Beat The Silent Disease of Osteoporosis with LAC, Before It’s Too Late!

SINGAPORE, Nov 18, 2024 - (ACN Newswire via SeaPRwire.com) - Despite Singapore’s abundant sunlight, Vitamin D deficiency remains a prevalent health issue, affecting millions of people. This deficiency significantly compromises bone health, leading to osteoporosis, a “silent disease” due to its subtle onset. Research indicates that bone health begins to decline at age 25, making it crucial to address this issue, especially as Singapore’s population continues to age. The urgency to combat this silent epidemic has never been greater.As sedentary lifestyles and poor dietary choices become increasingly common, the impact of osteoporosis is alarming: one in three women and one in five men over the age of 50 in Singapore are affected. Known as the “sunshine vitamin,” vitamin D plays a critical role in efficient calcium absorption, essential for maintaining bone density and preventing osteopenia and osteoporosis. Without adequate vitamin D, the body struggles to absorb calcium, increasing risk of fractures and leading to deteriorating bone health.In line with World Osteoporosis Day on 20 October, LAC (pronounced as L-A-C) is dedicated to raising awareness about the importance of bone health and empowering individuals to take preventive measures to optimise their bone density. By incorporating calcium-rich foods or supplements, ensuring adequate Vitamin D intake and regular physical activity, individuals can significantly reduce the risk of osteoporosis.LAC FullCal® combines calcium, magnesium and Vitamin D in a golden ratio, making it vital for maintaining strong bones, teeth and muscle function. This unique formula not only reduces the risk of osteoporosis but also improves calcium absorption, making it an excellent option for maintaining optimal bone health. With its all-in-one solution, individuals no longer need to rely on three separate supplements to achieve the same benefits, offering both enhanced convenience and cost savings.LAC Joint Protec®, formulated with a proprietary blend of ingredients such as Glucosamine, Chondroitin and Collagen, work together to alleviate joint stiffness and discomfort while enhancing mobility and flexibility. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
NTT and Olympus Demonstrate IOWN APN Low-latency Capability can be Used for Real-time Diagnosis and Treatment on Remote Server to Realize World’s First Cloud Endoscopy System JCN Newswire

NTT and Olympus Demonstrate IOWN APN Low-latency Capability can be Used for Real-time Diagnosis and Treatment on Remote Server to Realize World’s First Cloud Endoscopy System

News Highlights:By configuring the cloud endoscopy system with the latest IOWN APN1 (All Photonics Network; “APN”) technology, issues with latency were resolved, confirming that real-time diagnosis and treatment for patients through a remote server 150km away is feasible.Based on this result, NTT and Olympus will collaborate in studying the technical challenges towards the full-scale implementation of the cloud endoscopy system.TOKYO, Nov 19, 2024 - (JCN Newswire via SeaPRwire.com) - NTT Corporation (TSE: 9432; "NTT") and Olympus Corporation (TSE: 7733; "Olympus") today announced that, following the start of their joint experiment in March of the world’s first cloud endoscope system which processes endoscopic videos on the cloud, they jointly established a cloud endoscopy system utilizing the IOWN APN technology, and have demonstrated that the APN technology can solve network issues in realizing the cloud endoscopy system. Moving forward, the two companies will collaborate for the full-scale implementation of the cloud endoscopy system and enable performance and functional improvements of endoscopy systems through the cloud, contributing to society through improving access to advanced medical care.Parts of the results of this joint experiment will be exhibited at the NTT R&D FORUM 2024 - IOWN INTEGRAL2 event in Tokyo from November 25 to 29, 2024.Figure 1: Overview of Cloud Endoscopy SystemBackgroundAn endoscope is a medical device in which a flexible tube is inserted into the natural openings of the body to perform an examination and obtain tissue samples. Instances where endoscopes can be utilized are increasing year by year due to the equipment’s low level of invasiveness and high level of safety, and the technology is becoming increasingly sophisticated.However, current endoscopes handle all its functions within the endoscope device, making performance limitations and maintainability an issue. In addition, it is expected that more cases in the future will require flexible feature improvements and updates based on new user needs, such as real-time remote diagnosis and treatment. Therefore, there is discussion on cloud computing endoscopes, in which some functions with a high processing load, such as image processing, can be done on the cloud.To achieve image processing of endoscopes on the cloud, a network that connects the endoscope device and the cloud is vital. A lag in the network can lead to delay in the images in response to the endoscope operation, causing discomfort to the endoscopy operator. To prevent this, high-quality images captured by the endoscopy must be sent stably and with low-latency to an image processing system in the cloud, which has been a challenge.Overview of demonstration experimentThis demonstration experiment combined the advanced technology of Olympus’ endoscopes with NTT's high-speed, low-latency APN technology aimed at realizing real-time endoscope video processing in the cloud (Figure 1).(1) Configuration of the cloud endoscopy systemIn this joint demonstration experiment, we connected a video processing server (“server”), distanced 150km away from the device that inputs endoscopy images (“edge device”), to the APN and configured it as the cloud endoscopy system (Figure 2).The video captured by the endoscope was sent to the edge device via an endoscope processor, and then was transferred without any compressing to the server via the APN. The server then processed the video utilizing AI and other technology, and sent the processed video back to the edge device. Finally, the monitor which is connected to the edge device displayed the processed video for the endoscope operator to view.Figure 2: Configuration of the Cloud Endoscopy System and APN Experiment(2) Roles of each companyThe roles of each company for the demonstration experiment were divided as following.NTT:Provided the APN experiment environment and evaluated the APN connectivity and network quality.Olympus:Provided the endoscope device and evaluated the performance of the cloud endoscopy system and the processing capability of the software.Results of the joint demonstration experimentThe experiment used both a local configuration with a distance of 5m (assumed to be processed within the endoscope device) and an APN configuration with a distance of 150km which each processed the endoscopy video. The capture cards recorded the videos displayed on the endoscopy operator’s monitor, measured the network’s data latency, and compared the two videos (Figures 3 and 4).Due to the nature of endoscopy procedures, where operators perform examinations and surgeries while checking the video displayed on the monitor in real-time, the video captured by the scope needs to be processed and displayed without delay. If the video data (4K/60fps) is delayed even by a few frames, it will cause discomfort to the operator.This experiment was conducted with the goal of achieving a data transfer latency within 1 frame (under 16 milliseconds), considering the distance of approximately 150km. In result, the latency was 1.1 milliseconds, demonstrating that it was possible to transfer data at 1/10 of the target latency (Figure 5).Furthermore, regarding the difference between the videos processed locally and via the APN, a visual review by the operator confirmed that there was little difference in latency and fluctuation, demonstrating that latency in the APN would not be an issue in video processing.Through confirming that video processing between an edge device and a server separated by 150km is possible, this demonstrates the possibility of combining the video processing of hospitals in large areas, such as the entire metropolitan area, to a remote server, which is a valuable insight for the implementation of a cloud endoscopy system in the future.Figure 3: Connection Configuration of the Demonstration ExperimentFigure 4: Comparison of Processed Videos from APN Configuration and Local ConfigurationFigure 5: Result of Long-Distance (approx. 150km) Demonstration Experiment Using the APNIn light of these results, we were able to demonstrate that the APN can resolve network challenges related to a high-capacity network for transmitting high-quality images, which is necessary to realize the cloud computing of endoscopes, and a low-latency network for displaying inspection images without delay.OutlookMoving forward, the two companies will continue to study technical issues for social implementation of cloud endoscopy, such as advanced security measures for medical data in network transmission and real-time remote diagnosis and treatment by sharing image information among multiple hospitals.Through this initiative, NTT will establish a reference model for medical device networks that solves the various technical issues involved in the cloud computing of medical devices, and Olympus will contribute to the establishment of optimal networks and reference models for cloud endoscopy systems and other such systems.Terminology1. IOWN APN (All Photonics Network)The IOWN is comprised of three components: the "All Photonics Network (APN)," which makes it possible not only for networks but also for device processing; the "Digital Twin Computing," which enables advanced and real-time interaction between objects and humans in cyberspace; and the "Cognitive Foundation," which efficiently deploys various ICT resources.By introducing new optical technologies from the network to devices and chips, APN achieves ultra-low power consumption and ultra-high-speed processing, which has been difficult to achieve. By assigning wavelengths to each function on a single optical fiber, we can provide multiple functions that support our social infrastructure, including information and communication functions such as the Internet and sensing functions, without interfering with each other.2. NTT R&D FORUM 2024 - IOWN INTEGRAL official website: https://www.rd.ntt/e/forum/2024/About NTTNTT contributes to a sustainable society through the power of innovation. We are a leading global technology company providing services to consumers and business as a mobile operator, infrastructure, networks, applications, and consulting provider. Our offerings include digital business consulting, managed application services, workplace and cloud solutions, data center and edge computing, all supported by our deep global industry expertise. We are over $97B in revenue and 330,000 employees, with $3.6B in annual R&D investments. Our operations span across 80+ countries and regions, allowing us to serve clients in over 190 of them. We serve over 75% of Fortune Global 100 companies, thousands of other enterprise and government clients and millions of consumers.About OlympusAt Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global X account: @Olympus_Corp.Media contactsNTT IOWN Integrated Innovation CenterPublic Relationshttps://tools.group.ntt/en/rd/contact/index.php?param01=R¶m02=101Olympus CorporationPublic RelationsGlobal-Public_Relations@olympus.com Olympus Corp [TYO: 7733][ADR: OLYMY][FRA: OLYS] https://www.olympus-global.com Copyright 2024 JCN Newswire via SeaPRwire.com.
More